179 related articles for article (PubMed ID: 17382525)
1. Involvement of transient receptor potential proteins in cardiac hypertrophy.
Guinamard R; Bois P
Biochim Biophys Acta; 2007 Aug; 1772(8):885-94. PubMed ID: 17382525
[TBL] [Abstract][Full Text] [Related]
2. Effect of electroacupuncture on myocardial transient receptor potential channels in mice with myocardial hypertrophy.
Xie YH; Xing XY; Zhong W; Wu SB; Zhou MQ; Cui S
Zhen Ci Yan Jiu; 2024 Jun; 49(6):558-565. PubMed ID: 38897799
[TBL] [Abstract][Full Text] [Related]
3. Roles of TRP channels in the development of cardiac hypertrophy.
Nishida M; Kurose H
Naunyn Schmiedebergs Arch Pharmacol; 2008 Oct; 378(4):395-406. PubMed ID: 18600314
[TBL] [Abstract][Full Text] [Related]
4. [Mechanism of cardiac hypertrophy via diacylglycerol-sensitive TRPC channels].
Nishida M; Watanabe K; Nakaya M; Kurose H
Yakugaku Zasshi; 2010 Mar; 130(3):295-302. PubMed ID: 20190513
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of TRPC1 in the development of cardiac hypertrophy.
Ohba T; Watanabe H; Murakami M; Takahashi Y; Iino K; Kuromitsu S; Mori Y; Ono K; Iijima T; Ito H
J Mol Cell Cardiol; 2007 Mar; 42(3):498-507. PubMed ID: 17174323
[TBL] [Abstract][Full Text] [Related]
6. TRPC1 channels are critical for hypertrophic signaling in the heart.
Seth M; Zhang ZS; Mao L; Graham V; Burch J; Stiber J; Tsiokas L; Winn M; Abramowitz J; Rockman HA; Birnbaumer L; Rosenberg P
Circ Res; 2009 Nov; 105(10):1023-30. PubMed ID: 19797170
[TBL] [Abstract][Full Text] [Related]
7. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy.
Onohara N; Nishida M; Inoue R; Kobayashi H; Sumimoto H; Sato Y; Mori Y; Nagao T; Kurose H
EMBO J; 2006 Nov; 25(22):5305-16. PubMed ID: 17082763
[TBL] [Abstract][Full Text] [Related]
8. TRPC channels are necessary mediators of pathologic cardiac hypertrophy.
Wu X; Eder P; Chang B; Molkentin JD
Proc Natl Acad Sci U S A; 2010 Apr; 107(15):7000-5. PubMed ID: 20351294
[TBL] [Abstract][Full Text] [Related]
9. A background Ca2+ entry pathway mediated by TRPC1/TRPC4 is critical for development of pathological cardiac remodelling.
Camacho Londoño JE; Tian Q; Hammer K; Schröder L; Camacho Londoño J; Reil JC; He T; Oberhofer M; Mannebach S; Mathar I; Philipp SE; Tabellion W; Schweda F; Dietrich A; Kaestner L; Laufs U; Birnbaumer L; Flockerzi V; Freichel M; Lipp P
Eur Heart J; 2015 Sep; 36(33):2257-66. PubMed ID: 26069213
[TBL] [Abstract][Full Text] [Related]
10. Transient receptor potential: a large family of new channels of which several are involved in cardiac arrhythmia.
Vassort G; Alvarez J
Can J Physiol Pharmacol; 2009 Feb; 87(2):100-7. PubMed ID: 19234573
[TBL] [Abstract][Full Text] [Related]
11. TRP channels in disease.
Nilius B; Voets T; Peters J
Sci STKE; 2005 Aug; 2005(295):re8. PubMed ID: 16077087
[TBL] [Abstract][Full Text] [Related]
12. Murine cardiac growth, TRPC channels, and cGMP kinase I.
Domes K; Patrucco E; Loga F; Dietrich A; Birnbaumer L; Wegener JW; Hofmann F
Pflugers Arch; 2015 Oct; 467(10):2229-34. PubMed ID: 25547873
[TBL] [Abstract][Full Text] [Related]
13. Molecular and electrophysiological characterization of transient receptor potential ion channels in the primary murine megakaryocyte.
Carter RN; Tolhurst G; Walmsley G; Vizuete-Forster M; Miller N; Mahaut-Smith MP
J Physiol; 2006 Oct; 576(Pt 1):151-62. PubMed ID: 16857711
[TBL] [Abstract][Full Text] [Related]
14. TRP channels in kidney disease.
Hsu YJ; Hoenderop JG; Bindels RJ
Biochim Biophys Acta; 2007 Aug; 1772(8):928-36. PubMed ID: 17346947
[TBL] [Abstract][Full Text] [Related]
15. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling.
Bush EW; Hood DB; Papst PJ; Chapo JA; Minobe W; Bristow MR; Olson EN; McKinsey TA
J Biol Chem; 2006 Nov; 281(44):33487-96. PubMed ID: 16950785
[TBL] [Abstract][Full Text] [Related]
16. Screening of Transient Receptor Potential Canonical Channel Activators Identifies Novel Neurotrophic Piperazine Compounds.
Sawamura S; Hatano M; Takada Y; Hino K; Kawamura T; Tanikawa J; Nakagawa H; Hase H; Nakao A; Hirano M; Rotrattanadumrong R; Kiyonaka S; Mori MX; Nishida M; Hu Y; Inoue R; Nagata R; Mori Y
Mol Pharmacol; 2016 Mar; 89(3):348-63. PubMed ID: 26733543
[TBL] [Abstract][Full Text] [Related]
17. Resistance to pathologic cardiac hypertrophy and reduced expression of CaV1.2 in Trpc3-depleted mice.
Han JW; Lee YH; Yoen SI; Abramowitz J; Birnbaumer L; Lee MG; Kim JY
Mol Cell Biochem; 2016 Oct; 421(1-2):55-65. PubMed ID: 27522668
[TBL] [Abstract][Full Text] [Related]
18. The Ca(2+)-activated cation channel TRPM4 is a negative regulator of angiotensin II-induced cardiac hypertrophy.
Kecskés M; Jacobs G; Kerselaers S; Syam N; Menigoz A; Vangheluwe P; Freichel M; Flockerzi V; Voets T; Vennekens R
Basic Res Cardiol; 2015; 110(4):43. PubMed ID: 26043922
[TBL] [Abstract][Full Text] [Related]
19. Molecular changes in the early phase of renin-dependent cardiac hypertrophy in hypertensive cyp1a1ren-2 transgenic rats.
Kunert-Keil C; Landsberger M; Jantzen F; Niessner F; Kroemer HK; Felix SB; Brinkmeier H; Peters J
J Renin Angiotensin Aldosterone Syst; 2013 Mar; 14(1):41-50. PubMed ID: 23060473
[TBL] [Abstract][Full Text] [Related]
20. Role of TRPC3 and TRPC6 channels in the myocardial response to stretch: Linking physiology and pathophysiology.
Yamaguchi Y; Iribe G; Nishida M; Naruse K
Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):264-272. PubMed ID: 28645743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
